CS logo
small CS logo
Instytut Gruźlicy i Chorób Płuc, I Klinika Chorób Płuc

Warszawa, Poland
Research institute in Warsaw
Płocka 26, 01-138 Warszawa

About Instytut Gruźlicy i Chorób Płuc, I Klinika Chorób Płuc


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
4
Grifols Therapeutics LLC
2
National Institute for Tuberculosis and Lung Diseases, Poland
2
Boehringer Ingelheim
1
Corbus Pharmaceuticals Inc.
1
Eisai Inc.
1
FibroGen
1
Gilead Sciences
1
Savara Inc.
1
Total Rows: 9

Clinical Trials at Instytut Gruźlicy i Chorób Płuc, I Klinika Chorób Płuc


During the past decade, Instytut Gruźlicy i Chorób Płuc, I Klinika Chorób Płuc conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1111331111221100001122002200Started TrialsCompleted Trails201520162017201820192020202101234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer
2005-03-01
Completed
623
Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF)
2013-01-31
2016-02-23
Terminated
544
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
2013-10-13
2017-11-06
Completed
505
Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD)
2013-11-01
2026-06-01
Recruiting
339
Safety, Tolerability, Pharmacokinetics, and Efficacy of JBT-101 (Lenabasum) in Cystic Fibrosis
2015-09-29
2016-12-28
Completed
85
Long Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency
2016-07-01
2028-04-01
Enrolling by invitation
250
A Study to Assess Programmed Death Ligand-1 (PD-L1) Expression in Cytological Versus Histological Lung Cancer Specimens
2017-05-03
2018-06-06
Completed
184
A Study of Pirfenidone in Patients With Unclassifiable Progressive Fibrosing Interstitial Lung Disease
2017-05-15
2020-01-10
Completed
253

Rows per page:

1–14 of 14

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Instytut Gruźlicy i Chorób Płuc, I Klinika Chorób Płuc" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Grifols Therapeutics LLC" with 2 trials sponsored, "National Institute for Tuberculosis and Lung Diseases, Poland" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Corbus Pharmaceuticals Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Instytut Gruźlicy i Chorób Płuc, I Klinika Chorób Płuc" #1 collaborator was "Healthup Sp. z o.o." with 1 trials as a collaborator and "Medical University of Warsaw" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 4Hoffmann-La Roche: 4Grifols Therapeutics LLC: 2Grifols Therapeutics LLC: 2National Institute forTuberculosis and LungDiseases, Poland: 2National Institute forTuberculosis and LungDiseases, Poland: 2Boehringer Ingelheim: 1Boehringer Ingelheim: 1Corbus Pharmaceuticals Inc.: 1Corbus Pharmaceuticals Inc.: 1Eisai Inc.: 1Eisai Inc.: 1FibroGen: 1FibroGen: 1Gilead Sciences: 1Gilead Sciences: 1Savara Inc.: 1Savara Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsHealthup Sp. z o.o.: 1Healthup Sp. z o.o.: 1Medical University of Warsaw: 1Medical University of Warsaw: 1

Clinical Trials Conditions at Instytut Gruźlicy i Chorób Płuc, I Klinika Chorób Płuc


According to Clinical.Site data, the most researched conditions in "Instytut Gruźlicy i Chorób Płuc, I Klinika Chorób Płuc" are "Idiopathic Pulmonary Fibrosis" (3 trials), "Asthma" (1 trials), "Autoimmune Pulmonary Alveolar Proteinosis" (1 trials), "COPD" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Instytut Gruźlicy i Chorób Płuc, I Klinika Chorób Płuc" in a lesser frequency.

Clinical Trials Intervention Types at Instytut Gruźlicy i Chorób Płuc, I Klinika Chorób Płuc


Most popular intervention types in "Instytut Gruźlicy i Chorób Płuc, I Klinika Chorób Płuc" are "Drug" (9 trials), "Biological" (2 trials), "Other" (2 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Alpha-1 MP" (2 trials), "Pirfenidone" (2 trials), "0.9% Sodium Chloride for Injection, USP" (1 trials) and "AioCare" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Instytut Gruźlicy i Chorób Płuc, I Klinika Chorób Płuc


The vast majority of trials in "Instytut Gruźlicy i Chorób Płuc, I Klinika Chorób Płuc" are 14 trials for "All" genders.

Clinical Trials Status at Instytut Gruźlicy i Chorób Płuc, I Klinika Chorób Płuc


Currently, there are NaN active trials in "Instytut Gruźlicy i Chorób Płuc, I Klinika Chorób Płuc". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 7 completed trials in Instytut Gruźlicy i Chorób Płuc, I Klinika Chorób Płuc, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Instytut Gruźlicy i Chorób Płuc, I Klinika Chorób Płuc, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 5Phase 3: 5Phase 2: 4Phase 2: 4Not Applicable: 1Not Applicable: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 7Completed: 7Recruiting: 3Recruiting: 3Active, not recruiting: 2Active, not recruiting: 2Enrolling by invitation: 1Enrolling by invitation: 1Terminated: 1Terminated: 1